Literature DB >> 28499241

Pathophysiology, mechanisms and applications of mesenchymal stem cells for the treatment of spinal cord injury.

Pravin Shende1, Muna Subedi2.   

Abstract

Spinal Cord Injury (SCI) is a serious devastating condition associated to the high chances of morbidity and mortality. It involves a primary and a secondary injury, former cause damages to both lower and upper motor neurones and disrupts sensory, motor and autonomic functions while the latter involves various stages of molecular plus cellular incidents which elaborate the original injury. In the treatment of SCI, stem cells possess a good therapeutic potential. Bone marrow, adipose tissue, placenta, amniotic fluid and umbilical cord are the good sources for mesenchymal stem cells. This review article shows the uses of bone marrow derived mesenchymal cells in the treatment of acute and chronic case of SCI and its future scope.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Bone marrow; Mesenchymal cell; Spinal cord injury; Stem cells; Transplantation

Mesh:

Year:  2017        PMID: 28499241     DOI: 10.1016/j.biopha.2017.04.126

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  21 in total

Review 1.  Enhancing the Therapeutic Potential of Mesenchymal Stem Cells with the CRISPR-Cas System.

Authors:  Daniel Mendes Filho; Patrícia de Carvalho Ribeiro; Lucas Felipe Oliveira; Ana Luiza Romero Terra Dos Santos; Ricardo Cambraia Parreira; Mauro Cunha Xavier Pinto; Rodrigo Ribeiro Resende
Journal:  Stem Cell Rev Rep       Date:  2019-08       Impact factor: 5.739

Review 2.  Effects of mesenchymal stem cell transplantation on spinal cord injury patients.

Authors:  Fatemeh Tahmasebi; Shirin Barati
Journal:  Cell Tissue Res       Date:  2022-06-14       Impact factor: 4.051

Review 3.  Mesenchymal Stem Cell Therapy: A Potential Treatment Targeting Pathological Manifestations of Traumatic Brain Injury.

Authors:  Kaige Zhang; Yiming Jiang; Biyao Wang; Tiange Li; Dehao Shang; Xinwen Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-06-15       Impact factor: 7.310

4.  Extracellular vesicles derived from mesenchymal stem cells containing microRNA-381 protect against spinal cord injury in a rat model via the BRD4/WNT5A axis.

Authors:  Xufeng Jia; Guangping Huang; Shaohua Wang; Miao Long; Xiaojun Tang; Daxiong Feng; Qingzhong Zhou
Journal:  Bone Joint Res       Date:  2021-05       Impact factor: 5.853

Review 5.  Mesenchymal Stem/Stromal Cell-Mediated Mitochondrial Transfer and the Therapeutic Potential in Treatment of Neurological Diseases.

Authors:  Deqiang Han; Xin Zheng; Xueyao Wang; Tao Jin; Li Cui; Zhiguo Chen
Journal:  Stem Cells Int       Date:  2020-07-07       Impact factor: 5.443

6.  IGF-1 overexpression improves mesenchymal stem cell survival and promotes neurological recovery after spinal cord injury.

Authors:  Kyan James Allahdadi; Thaís Alves de Santana; Girlaine Café Santos; Carine Machado Azevedo; Roberta Alves Mota; Carolina Kymie Nonaka; Daniela Nascimento Silva; Clarissa Xavier Resende Valim; Cláudio Pereira Figueira; Washington Luis Conrado Dos Santos; Renan Fernandes do Espirito Santo; Afrânio Ferreira Evangelista; Cristiane Flora Villarreal; Ricardo Ribeiro Dos Santos; Bruno Solano Freitas de Souza; Milena Botelho Pereira Soares
Journal:  Stem Cell Res Ther       Date:  2019-05-21       Impact factor: 6.832

7.  Human gingival mesenchymal stem cells pretreated with vesicular moringin nanostructures as a new therapeutic approach in a mouse model of spinal cord injury.

Authors:  Santa Mammana; Agnese Gugliandolo; Eugenio Cavalli; Francesca Diomede; Renato Iori; Romina Zappacosta; Placido Bramanti; Pio Conti; Antonella Fontana; Jacopo Pizzicannella; Emanuela Mazzon
Journal:  J Tissue Eng Regen Med       Date:  2019-05-31       Impact factor: 3.963

8.  A mouse model of complete-crush transection spinal cord injury made by two operations.

Authors:  Chen Li; Xingfei Zhu; Chia-Ming Lee; Zhourui Wu; Liming Cheng
Journal:  Ann Transl Med       Date:  2020-03

9.  Human umbilical cord mesenchymal stem cells to treat spinal cord injury in the early chronic phase: study protocol for a prospective, multicenter, randomized, placebo-controlled, single-blinded clinical trial.

Authors:  Yang Yang; Mao Pang; Yu-Yong Chen; Liang-Ming Zhang; Hao Liu; Jun Tan; Bin Liu; Li-Min Rong
Journal:  Neural Regen Res       Date:  2020-08       Impact factor: 5.135

10.  Smooth muscle cells differentiated from mesenchymal stem cells are regulated by microRNAs and suitable for vascular tissue grafts.

Authors:  Wenduo Gu; Xuechong Hong; Alexandra Le Bras; Witold N Nowak; Shirin Issa Bhaloo; Jiacheng Deng; Yao Xie; Yanhua Hu; Xiong Z Ruan; Qingbo Xu
Journal:  J Biol Chem       Date:  2018-04-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.